Peak oxygen uptake (V˙O2peak) is frequently difficult to assess in overweight individuals; therefore, submaximal measures that predict V˙O2peak are proposed as substitutes. Oxygen uptake efficiency slope (OUES) has been suggested as a submaximal measurement of cardiorespiratory fitness that is independent of exercise intensity. There are few data examining its value as a predictor of V˙O2peak in severely overweight adolescents.
One hundred seven severely overweight (BMI Z 2.50 ± 0.34) and 43 nonoverweight (BMI Z 0.13 ± 0.84) adolescents, performed a maximal cycle ergometer test with respiratory gas-exchange measurements. OUES was calculated through three exercise intensities: lactate inflection point (OUES LI), 150% of lactate inflection point (OUES 150), and V˙O2peak (OUES PEAK).
When adjusted for lean body mass, V˙O2peak and OUES at all exercise intensities were lower in overweight subjects (V˙O2peak: 35.3 ± 6.4 vs 46.8 ± 7.9 mL·kg−1 LBM·min−1, P < 0.001; OUES LI: 37.9 ± 10.0 vs 43.7 ± 9.2 mL·kg−1 LBM·min−1·logL−1 P < 0.001; OUES 150: 41.6 ± 9.0 vs 49.8 ± 11.1 mL·kg−1 LBM·min−1·logL−1 P < 0.001; and OUES PEAK: 45.1 ± 8.7 vs 52.8 ± 9.6 mL·kg−1 LBM·min−1·logL−1 P < 0.001). There was a significant increase in OUES with increasing exercise intensity in both groups (P < 0.001). OUES at all exercise intensities was a significant predictor of V˙O2peak for both groups (r 2 = 0.35-0.83, P < 0.0001). However, limits of agreement for predicted V˙O2peak relative to actual V˙O2peak were wide (± 478 to ± 670 mL·min−1).
OUES differs significantly in overweight and nonoverweight adolescents. The wide interindividual variation and the exercise intensity dependence of OUES preclude its use in clinical practice as a predictor of V˙O2peak.
1Rehabilitation Medicine Department, Mark O. Hatfield Clinical Research Center, National Institutes of Health, Bethesda, MD; 2Unit on Growth and Obesity, Developmental Endocrinology Branch, and 3Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development, Bethesda, MD; and 4NIH Clinical Center, National Institutes of Health, Bethesda, MD
Address for correspondence: Jack A. Yanovski, M.D., Ph.D., Head, Unit on Growth and Obesity, DEB, NICHD, National Institutes of Health, Building CRC Room 1-1330, 10 Center Drive MSC 1103, Bethesda, MD 20892-1103; E-mail: firstname.lastname@example.org.
Submitted for publication March 2007.
Accepted for publication May 2007.